5097 related articles for article (PubMed ID: 18048761)
1. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
2. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
[TBL] [Abstract][Full Text] [Related]
3. Myocardial protection in reperfusion with postconditioning.
Vinten-Johansen J; Zhao ZQ; Jiang R; Zatta AJ
Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1035-45. PubMed ID: 16292995
[TBL] [Abstract][Full Text] [Related]
4. Realizing the clinical potential of ischemic preconditioning and postconditioning.
Yellon DM; Hausenloy DJ
Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
[TBL] [Abstract][Full Text] [Related]
5. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury.
Vinten-Johansen J; Zhao ZQ; Zatta AJ; Kin H; Halkos ME; Kerendi F
Basic Res Cardiol; 2005 Jul; 100(4):295-310. PubMed ID: 15793629
[TBL] [Abstract][Full Text] [Related]
6. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
[TBL] [Abstract][Full Text] [Related]
7. Loss of cardioprotection with ageing.
Boengler K; Schulz R; Heusch G
Cardiovasc Res; 2009 Jul; 83(2):247-61. PubMed ID: 19176601
[TBL] [Abstract][Full Text] [Related]
8. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.
Hausenloy DJ; Tsang A; Yellon DM
Trends Cardiovasc Med; 2005 Feb; 15(2):69-75. PubMed ID: 15885573
[TBL] [Abstract][Full Text] [Related]
9. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
[TBL] [Abstract][Full Text] [Related]
10. [Postconditioning: a brief review].
Schipke JD; Kerendi F; Gams E; Vinten-Johansen J
Herz; 2006 Sep; 31(6):600-6. PubMed ID: 17036192
[TBL] [Abstract][Full Text] [Related]
11. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
Vinten-Johansen J; Shi W
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):260-6. PubMed ID: 21821526
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
Skyschally A; Schulz R; Heusch G
Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
[TBL] [Abstract][Full Text] [Related]
13. Postconditioning: reduction of reperfusion-induced injury.
Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
[TBL] [Abstract][Full Text] [Related]
14. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.
Ferdinandy P; Hausenloy DJ; Heusch G; Baxter GF; Schulz R
Pharmacol Rev; 2014 Oct; 66(4):1142-74. PubMed ID: 25261534
[TBL] [Abstract][Full Text] [Related]
15. [Can any heart be preconditioned? Influence of aging and comorbidities on cardioprotection].
Bilińska M
Kardiol Pol; 2011; 69 Suppl 3():85-8. PubMed ID: 22125209
[TBL] [Abstract][Full Text] [Related]
16. [Ischemic postconditioning: an effective strategy of myocardial protection?].
Rastaldo R; Penna C; Cappello S; Mancardi D; Pagliaro P; Losano G
G Ital Cardiol (Rome); 2006 Jul; 7(7):464-73. PubMed ID: 16977786
[TBL] [Abstract][Full Text] [Related]
17. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
Sivarajah A; McDonald MC; Thiemermann C
Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
[TBL] [Abstract][Full Text] [Related]
18. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
19. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways.
Yang XM; Proctor JB; Cui L; Krieg T; Downey JM; Cohen MV
J Am Coll Cardiol; 2004 Sep; 44(5):1103-10. PubMed ID: 15337225
[TBL] [Abstract][Full Text] [Related]
20. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
Das B; Sarkar C
J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
